Evidence for association between hepatitis C virus and Parkinson’s disease

Ribavirin free versus Ribavirin containing therapy with all second generation direct acting antivirals for the treatment of hepatitis C virus genotype 1 infection; a pooled analysis of 4501 patients

(2017) H. Ahmed et al.   JOURNAL OF HEPATOLOGY

Viral hepatitis and the risk of Parkinson disease

(2017) Julián Benito-León   NEUROLOGY

Viral hepatitis and Parkinson disease

(2017) Julia Pakpoor et al.   NEUROLOGY

Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

(2016) Hussien Ahmed et al.   ANTIVIRAL THERAPY

Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons

(2016) Kirk J. Wangensteen et al.   CLINICAL NEUROPHARMACOLOGY

Re: Wangensteenet al. of a letter on ‘Hepatitis C virus infection: a risk factor for Parkinson's disease.'

(2016) H.-H. Chen et al.   JOURNAL OF VIRAL HEPATITIS

Association between hepatitis C virus infection and Parkinson's disease

(2016) Jong-Min Kim et al.   MOVEMENT DISORDERS

Oxidative and nitrosative stress in serum of patients with Parkinson’s disease

(2016) Hikmet Can Çubukçu et al.   NEUROLOGICAL SCIENCES

Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype

(2016) Renato P. Munhoz et al.   NEUROLOGICAL SCIENCES

Comparison of neutrophil–lymphocyte ratio (NLR) in Parkinson’s disease subtypes

(2016) Ceyla Ataç Uçar et al.   NEUROLOGICAL SCIENCES

Hepatitis C virus infection: a risk factor for Parkinson's disease

(2015) W. Y.-Y. Wu et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C virus infection as a risk factor for Parkinson disease

(2015) Hsin-Hsi Tsai et al.   NEUROLOGY

Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings

(2015) Silvana S. Bettiol et al.   Journal of Parkinsons Disease

Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in Parkinson's Disease Brain is Region Dependent

(2014) Paula Garcia-Esparcia et al.   BRAIN PATHOLOGY

The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease

(2014) Eşref Akıl et al.   NEUROLOGICAL SCIENCES

Curing Chronic Hepatitis C — The Arc of a Medical Triumph

(2014) Raymond T. Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Parkinson disease: from pathology to molecular disease mechanisms

(2013) David T. Dexter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease

(2013) Juliet M. Taylor et al.   NEUROCHEMISTRY INTERNATIONAL

Hepatitis C Virus Infects the Endothelial Cells of the Blood-Brain Barrier

(2011) Nicola F. Fletcher et al.   GASTROENTEROLOGY

S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures

(2011) Graham K. Sheridan et al.   GLIA

Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy

(2010) Li Qian et al.   JOURNAL OF NEURAL TRANSMISSION

Interferon-induced parkinsonism in a patient with chronic hepatitis C

(2009) Carlos Mauricio Oliveira de Almeida et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY

Hepatitis C Virus Infection and Hepatocellular Carcinoma

(2008) Wojciech Blonski et al.   Clinics in Liver Disease

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

(2008) Vanessa Brochard et al.   JOURNAL OF CLINICAL INVESTIGATION

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Regional Susceptibility to Domoic Acid in Primary Astrocyte Cells Cultured from the Brain Stem and Hippocampus

(2008) Santokh Gill et al.   Marine Drugs

Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

(2008) W. G. Stetler-Stevenson   Science Signaling